[1]
“Efficacy of Bortezomib plus dexamethasone as a first line treatment in newly diagnosed cases of Multiple Myeloma: A Single Centre Study in a Tertiary Care Hospital”, J Dhaka Med Coll, vol. 28, no. 1, pp. 34–41, Mar. 2020, doi: 10.3329/jdmc.v28i1.45754.